TAXUS EXPRESS2 PACLITAXEL-ELUTING CORONARY STENT SYSTEM
Report
- Report Number
- 2134265-2010-05609
- Event Type
- Injury
- Date Received
- December 20, 2010
- Date of Event
- January 17, 2010
- Report Date
- November 22, 2010
- Manufacturer
- BOSTON SCIENTIFIC - GALWAY
- Product Code
- NIQ
- PMA / PMN Number
- P030025
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- PHYSICIAN
Narratives
(B)(4): IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE BATCH HISTORY, HISTORICAL TRENDING, AND SIMILAR COMPLAINT TRENDING REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED. (B)(4)
(B)(4).
(B)(4).
(B)(4). SAME CASE AS MFR REPORT #: 2134265-2010-05605, 2134265-2010-05606, 2134265-2010-05608. IT WAS REPORTED THAT FOLLOWING A STENTING TREATMENT PROCEDURE, AN ACUTE MYOCARDIAL INFARCTION OCCURRED. THE INDEX PROCEDURE PLACED 3 UNSPECIFIED TAXUS EXPRESS2 STENTS IN THE PROXIMAL RIGHT CORONARY ARTERY AND 1 UNSPECIFIED TAXUS EXPRESS2 STENT IN THE DISTAL CIRCUMFLEX ARTERY. IN (B)(6) 2010, THE PATIENT EXPERIENCED AN ACUTE MYOCARDIAL INFARCTION (INFERIOR WALL). A TARGET LESION REVASCULARIZATION WAS PERFORMED. PER THE PHYSICIAN, THE MYOCARDIAL INFARCTION WAS LISTED AS "DEFINITELY RELATED" TO THE STUDY STENTS AND POSSIBLY RELATED TO THE ANTIPLATELETS. IN (B)(6) 2010, THE PATIENT DEVELOPED CHOLEDOCHOLITHIASIS ANGIOCHOLITIS AND DIED. PER THE PHYSICIAN, THE DEATH EVENT WAS LISTED AS "UNRELATED" TO THE STUDY STENTS.
IT WAS FURTHER REPORTED THAT THE PROXIMAL RIGHT CORONARY ARTERY (RCA) WAS TREATED WITH THREE TAXUS EXPRESS2 STENTS (2.75X28MM, 3.0X32MM, 3.5X12MM) AFTER PRE-DILATION. POST-IVUS WAS PERFORMED CONFIRMING THE STENTS WERE EXPANDED WELL WITH 0% RESIDUAL STENOSIS. THE DISTAL CIRCUMFLEX ARTERY WAS TREATED WITH A 3.0X28MM TAXUS EXPRESS2 STENT AFTER PRE-DILATION. POST-IVUS WAS PERFORMED CONFIRMING THE STENT WAS EXPANDED WELL RESULTING IN 0% RESIDUAL STENOSIS. THE PATIENT HAD NO ANGINAL SYMPTOMS AT THE 1 MONTH, 6 MONTH, 9 MONTH AND 1 YEAR FOLLOW UP VISITS. AT THE TIME OF MYOCARDIAL INFARCTION, THE TARGET LESION REVASCULARIZATION WAS PERFORMED IN THE 100% STENOSED, 3.0MM IN DIAMETER LESION LOCATED IN THE MID RCA. TREATMENT UTILIZED BALLOON ANGIOPLASTY RESULTING IN 25% RESIDUAL STENOSIS. THE PATIENT WAS DISCHARGED 11 DAYS LATER IN IMPROVED CONDITION. IN 02/2010, ENDOSCOPIC INSPECTION AND TREATMENT WERE PERFORMED FOR THE CHOLEDOCHOLITHIASIS ANGIOCHOLITIS. THE PATIENT DEVELOPED BLOOD POISONING AND DIED DUE TO MULTI ORGAN FAILURE.
IT WAS FURTHER REPORTED THAT THE INDEX PROCEDURE TREATED THE DE NOVO, 100% STENOSED 3.3X16MM TARGET LESION LOCATED IN THE PROXIMAL RIGHT CORONARY ARTERY (RCA). THE 3 STENTS PLACED IN THE PROXIMAL RCA WERE OVERLAPPING. NO POST DILATION WAS PERFORMED. THE LESION LOCATED IN THE DISTAL LEFT CIRCUMFLEX (LCX) ARTERY WAS A DE NOVO, 90% STENOSED 3.3X5.2MM TARGET LESION. POST DILATION WAS NOT PERFORMED. THE PATIENT WAS DISCHARGED WITHOUT COMPLICATION THE NEXT DAY ON BAYASPIRIN AND PANALDINE. PER THE PHYSICIAN, THE ACUTE MI EVENT WAS LISTED AS "DEFINITELY RELATED" TO THE STUDY STENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | TAXUS EXPRESS2 PACLITAXEL-ELUTING CORONARY STENT SYSTEM | CORONARY DRUG-ELUTING STENT | NIQ | BOSTON SCIENTIFIC - GALWAY | H7493897032300 | 11177527 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 73 YR | Hospitalization| R | 3.5X12 TAXUS EXPRESS2 STENTTAXUS EXPRESS 2 STENT| 3.0X28 TAXUS EXPRESS2 STENT| 2.75X28 TAXUS EXPRESS2 STENT |